312 related articles for article (PubMed ID: 24718882)
1. [Social phobia].
Bandelow B; Wedekind D
Nervenarzt; 2014 May; 85(5):635-44; quiz 645-7. PubMed ID: 24718882
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for social anxiety disorder: an update.
Van Ameringen M; Mancini C; Patterson B; Simpson W
Isr J Psychiatry Relat Sci; 2009; 46(1):53-61. PubMed ID: 19728573
[TBL] [Abstract][Full Text] [Related]
3. [Social anxiety disorders].
Renneberg B; Ströhle A
Nervenarzt; 2006 Sep; 77(9):1123-31; quiz 1132. PubMed ID: 16710727
[TBL] [Abstract][Full Text] [Related]
4. WCA recommendations for the long-term treatment of social phobia.
Van Ameringen M; Allgulander C; Bandelow B; Greist JH; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP;
CNS Spectr; 2003 Aug; 8(8 Suppl 1):40-52. PubMed ID: 14767397
[TBL] [Abstract][Full Text] [Related]
5. [Neurobiology and pharmacotherapy of social phobia].
Aouizerate B; Martin-Guehl C; Tignol J
Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine in social phobia.
Kelsey JE
Psychopharmacol Bull; 1995; 31(4):767-71. PubMed ID: 8851651
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
Altamura AC; Pioli R; Vitto M; Mannu P
Int Clin Psychopharmacol; 1999 Jul; 14(4):239-45. PubMed ID: 10468317
[TBL] [Abstract][Full Text] [Related]
8. The role of drug therapy in social phobia.
Lydiard RB
J Affect Disord; 1998 Sep; 50 Suppl 1():S35-9. PubMed ID: 9851577
[TBL] [Abstract][Full Text] [Related]
9. [Social phobia--no common shyness].
Furmark T; Hedman E; Tillfors M; Ekselius L
Lakartidningen; 2011 Apr 6-12; 108(14):802-5. PubMed ID: 21638921
[No Abstract] [Full Text] [Related]
10. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
11. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.
Brunello N; den Boer JA; Judd LL; Kasper S; Kelsey JE; Lader M; Lecrubier Y; Lepine JP; Lydiard RB; Mendlewicz J; Montgomery SA; Racagni G; Stein MB; Wittchen HU
J Affect Disord; 2000 Oct; 60(1):61-74. PubMed ID: 10940449
[TBL] [Abstract][Full Text] [Related]
12. A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.
Pacchiarotti I; Manfredi G; Kotzalidis GD; Ruberto A; Tatarelli R; Girardi P
Eur Psychiatry; 2004 Jun; 19(4):233-4. PubMed ID: 15196607
[TBL] [Abstract][Full Text] [Related]
13. Substance use and the treatment of resistant depression in adolescents.
Goldstein BI; Shamseddeen W; Spirito A; Emslie G; Clarke G; Wagner KD; Asarnow JR; Vitiello B; Ryan N; Birmaher B; Mayes T; Onorato M; Zelazny J; Brent DA
J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1182-92. PubMed ID: 19858762
[TBL] [Abstract][Full Text] [Related]
14. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
[TBL] [Abstract][Full Text] [Related]
15. [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
Rachin AP; Sergeev AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):68-70. PubMed ID: 19938277
[No Abstract] [Full Text] [Related]
16. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
17. Social phobia: maintenance models and main components of CBT.
Marom S; Aderka IM; Hermesh H; Gilboa-Schechtman E
Isr J Psychiatry Relat Sci; 2009; 46(4):264-8. PubMed ID: 20635773
[TBL] [Abstract][Full Text] [Related]
18. [Cannabis dependence and social phobia].
Dervaux A
Encephale; 2005 Oct; 31 Pt 2():S47-8. PubMed ID: 16673708
[No Abstract] [Full Text] [Related]
19. [Anxiety disorders: diagnosis and therapy from the family physician's perspective].
Boerner RJ
MMW Fortschr Med; 2006 May; Spec no. 2():62, 64-6. PubMed ID: 20104717
[TBL] [Abstract][Full Text] [Related]
20. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
Thase ME; Entsuah AR; Rudolph RL
Br J Psychiatry; 2001 Mar; 178():234-41. PubMed ID: 11230034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
